Stock Based Compensation - Omnibus Incentive Plan (Details) - Omnibus Plan - Stock Options - $ / shares		3 Months Ended	12 Months Ended
	May 27, 2021	Mar. 31, 2022	Dec. 31, 2021
Stock based compensation
Number of additional shares authorized	1,000,000
Number of shares available for grant	2,200,000	940,221
Stock options granted (in shares)		10,888
Number of shares
Balance at beginning of year (in shares)		778,835
Granted (in shares)		10,888
Forfeited (in shares)		(3,870)
Balance at end of year (in shares)		785,853	778,835
Options: Options vested and exercisable		651,478
Options: Options vested and expected to vest		785,853
Weighted-Average Exercise Price
Balance at beginning of year (in dollars per share)		$ 18.02
Granted (in dollars per share)		14.32
Forfeited (in dollars per share)		29.62
Balance at end of year (in dollars per share)		17.91	$ 18.02
Weighted-Average Exercise Price: Options vested and exercisable		15.76
Weighted-Average Exercise Price: Options vested and expected to vest		$ 17.91
Weighted- Average Remaining Contractual Term (in Years)
Balance (in years)		5 years 4 months 9 days	5 years 7 months 2 days
Granted (in years)		6 years 10 months 28 days
Weighted-Average Remaining Contractual Term (in Years): Options vested and exercisable		5 years 1 month 13 days
Weighted-Average Remaining Contractual Term (in Years): Options vested and expected to vest		5 years 4 months 9 days
Number of unvested options scheduled to vest
Non-Vested Options as of beginning of period		127,357
Granted (in shares)		10,888
Forfeited (in shares)		(3,870)
Non-Vested Options as of end of period		134,375	127,357
Weighted-Average Grant Date Fair Value
Non-Vested, beginning balance		$ 17.42
Granted: Weighted-Average Grant Date Fair Value		8.49
Forfeited: Weighted-Average Grant Date Fair Value		17.43
Non-Vested, ending balance		$ 16.70	$ 17.42
Valuation Assumptions:
Expected term in years		4 years 3 months
Volatility (as a percent)		77.44%
Risk-free interest rate		1.91%
Dividend yield (as a percent)		0.00%
Granted: Weighted-Average Grant Date Fair Value		$ 8.49
2022
Number of unvested options scheduled to vest
Non-Vested Options as of end of period		134,375
Valuation Assumptions:
Term of award		P7Y
Vesting period		2 years